Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution

Figure 4

EZH2 expression levels with specific karyotypic patterns: normal karyotypes (NK), −7 and del(7q), +8, del(11q).